Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations [2]

Inflammatory Bowel Diseases

Volumn 13, Issue 4, 2007, Pages 504-505

  Koutroubakis, Ioannis E ^a   Karmiris, Konstantinos ^a   Bourikas, Leonidas ^a   Kouroumalis, Elias A ^a   Drygiannakis, Ioannis ^b   Drygiannakis, Dimitrios ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b General Hospital of Rethymnon   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY;

ANKYLOSING SPONDYLITIS; ARTHRITIS; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; PREVALENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SACROILIITIS; ULCERATIVE COLITIS;

ADULT; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GREECE; HUMANS; INFLAMMATORY BOWEL DISEASES; PEPTIDES, CYCLIC;

EID: 34247641575     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20038     Document Type: Letter

References (8)

1. De Vos M. Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(suppl 4):36-42.
2. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65:845-851.
3. Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxf) 2006;45:20-25.
4. Vander Cruyssen B, Hoffman IE, Zmierczak H, et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis. 2005;64:1145-1149.
5. Bogliolo L, Alpini C, Caporali R, et al. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol. 2005;32:511-515.
6. Alenius GM, Berglin E, Rantapaa Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006;65:398-400.
7. Braun-Moscovici Y, Markovits D, Zinder O, et al. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis. J Rheumatol. 2006;33:497-500.
8. Generini S, Giacomelli R, Fedi R, et al. Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann Rheum Dis. 2004;63:1664-1669.